Authors:
RABOUD JM
SINGER J
THORNE A
SCHECHTER MT
SHAFRAN SD
Citation: Jm. Raboud et al., ESTIMATING THE EFFECT OF TREATMENT ON QUALITY-OF-LIFE IN THE PRESENCEOF MISSING DATA DUE TO DROP-OUT AND DEATH, Quality of life research, 7(6), 1998, pp. 487-494
Authors:
DIAZMITOMA F
SIBBALD RG
SHAFRAN SD
BOON R
SALTZMAN RL
Citation: F. Diazmitoma et al., ORAL FAMCICLOVIR FOR THE SUPPRESSION OF RECURRENT GENITAL HERPES - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 280(10), 1998, pp. 887-892
Authors:
SACKS SL
SHAFRAN SD
DIAZMITOMA F
TROTTIER S
SIBBALD RG
HUGHES A
SAFRIN S
RUDY J
MCGUIRE B
JAFFE HS
Citation: Sl. Sacks et al., A MULTICENTER PHASE I II DOSE-ESCALATION STUDY OF SINGLE-DOSE CIDOFOVIR GEL FOR TREATMENT OF RECURRENT GENITAL HERPES/, Antimicrobial agents and chemotherapy, 42(11), 1998, pp. 2996-2999
Authors:
SHAFRAN SD
SINGER J
ZAROWNY DP
DESCHENES J
PHILLIPS P
TURGEON F
AOKI FY
TOMA E
MILLER M
DUPERVAL R
LEMIEUX C
SCHLECH WF
Citation: Sd. Shafran et al., DETERMINANTS OF RIFABUTIN-ASSOCIATED UVEITIS IN PATIENTS TREATED WITHRIFABUTIN CLARITHROMYCIN, AND ETHAMBUTOL FOR MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA - A MULTIVARIATE-ANALYSIS, The Journal of infectious diseases, 177(1), 1998, pp. 252-255
Citation: Sd. Shafran et Jm. Conly, DOES CHLAMYDIA-PNEUMONIAE CAUSE CORONARY ATHEROSCLEROSIS AND SHOULD WE ALL TAKE MACROLIDES, Canadian journal of cardiology, 13(11), 1997, pp. 1017-1019
Authors:
GARTON AM
RENNIE RP
GILPIN J
MARRELLI M
SHAFRAN SD
Citation: Am. Garton et al., COMPARISON OF DOSE DOUBLING WITH PROBENECID FOR SUSTAINING SERUM CEFUROXIME LEVELS, Journal of antimicrobial chemotherapy, 40(6), 1997, pp. 903-906
Citation: Sd. Shafran et al., TOPICAL UNDECYLENIC ACID FOR HERPES-SIMPLEX LABIALIS - A MULTICENTER,PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 176(1), 1997, pp. 78-83
Citation: Dd. Sin et Sd. Shafran, DAPSONE-INDUCED AND PRIMAQUINE-INDUCED METHEMOGLOBINEMIA IN HIV-INFECTED INDIVIDUALS, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 477-481
Citation: Sl. Sacks et al., PATIENT-INITIATED, TWICE-DAILY ORAL FAMCICLOVIR FOR EARLY RECURRENT GENITAL HERPES - A RANDOMIZED, DOUBLE-BLIND MULTICENTER TRIAL, JAMA, the journal of the American Medical Association, 276(1), 1996, pp. 44-49
Authors:
SHAFRAN SD
SINGER J
ZAROWNY DP
PHILLIPS P
SALIT I
WALMSLEY SL
FONG IW
GILL MJ
RACHLIS AR
LALONDE RG
FANNING MM
TSOUKAS CM
Citation: Sd. Shafran et al., A COMPARISON OF 2 REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN AIDS - RIFABUTIN, ETHAMBUTOL, AND CLARITHROMYCIN VERSUS RIFAMPIN, ETHAMBUTOL, CLOFAZIMINE, AND CIPROFLOXACIN, The New England journal of medicine, 335(6), 1996, pp. 377-383
Citation: Sd. Shafran et al., DISSEMINATED MYCOBACTERIUM-GENAVENSE INFECTION IN CANADIAN AIDS PATIENTS, Tubercle and lung disease, 76(2), 1995, pp. 168-170
Authors:
SHAFRAN SD
DESCHENES J
MILLER M
PHILLIPS P
TOMA E
Citation: Sd. Shafran et al., UVEITIS AND PSEUDOJAUNDICE DURING A REGIMEN OF CLARITHROMYCIN, RIFABUTIN, AND ETHAMBUTOL, The New England journal of medicine, 330(6), 1994, pp. 438-439
Citation: Jct. Galbraith et Sd. Shafran, HERPES-SIMPLEX ESOPHAGITIS IN THE IMMUNOCOMPETENT PATIENT - REPORT OF4 CASES AND REVIEW, Clinical infectious diseases, 14(4), 1992, pp. 894-901